PMDA drug package insert
カラシミンＣ顆粒（分包）
PMDA OTC drug · カラシミンＣ顆粒（分包） · package insert Mar 24, 2007
Key facts
| Brand names | カラシミンＣ顆粒（分包） |
|---|---|
| Companies | 製造販売元／鶴原製薬（株）,販売会社／カラシミンＣ顆粒（分包） |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | ビタミンC主薬製剤 |
| Package insert date | Mar 24, 2007 |
| PMDA document key | 460028_J0601004116 |
| PMDA company code | 460028 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: